Video: Bank of Mexico’s Duclaud says new rules will hit sterilisation costs

The introduction of the Dodd-Frank Act in the US and the Basel Committee on Banking Supervision's Basel III capital accord around the world look set to drive up the costs of central bank sterilisation efforts in countries with relatively open markets.

"Many banks around the world have become much more conservative in their market practices and the tolerance with regard to the credit and market risk they can bear in the face of new regulations," Javier Duclaud, head of banking operations at the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.centralbanking.com/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Central Banking account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: